Lifevantage (LFVN)
Lifevantage on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
976K
Short interest
settlement 2026-10-15
28.8
Days to cover
-3.8 days vs prior
59.4%
Short share of volume
2026-11-02
987
Fails to deliver
settlement 2026-10-14
Tue 3 Nov
Next earnings
estimated date
-$50K
Insider flow, 90 days
1 buys, 2 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in LFVN is 976,051 shares, down 161,855 shares over the last month. Over the last 48 readings it ranged from 191,007 shares (15 January 2025) to 3,853,011 shares (30 April 2026). At the reported average volume of 34K shares a day that is 28.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/lfvn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 976,051 | -8.6% | 33,935 | 28.76 |
| 2026-09-30 | 1,068,085 | -6.1% | 32,754 | 32.61 |
| 2026-09-15 | 1,137,906 | -6.8% | 48,138 | 23.64 |
| 2026-08-31 | 1,221,521 | +1.1% | 54,973 | 22.22 |
| 2026-08-14 | 1,207,968 | -4.4% | 57,105 | 21.15 |
| 2026-07-31 | 1,263,292 | -13.9% | 72,742 | 17.37 |
| 2026-07-15 | 1,467,409 | -21.8% | 184,284 | 7.96 |
| 2026-06-30 | 1,877,105 | -33.5% | 443,984 | 4.23 |
| 2026-06-15 | 2,824,413 | -20.3% | 1,302,475 | 2.17 |
| 2026-05-29 | 3,544,182 | -1.3% | 364,832 | 9.71 |
| 2026-05-15 | 3,590,981 | -6.8% | 260,290 | 13.80 |
| 2026-04-30 | 3,853,011 | +2.8% | 257,066 | 14.99 |
| 2026-04-15 | 3,746,847 | +1.2% | 107,567 | 34.83 |
| 2026-03-31 | 3,703,567 | -0.4% | 82,713 | 44.78 |
| 2026-03-13 | 3,719,846 | -0.0% | 133,672 | 27.83 |
| 2026-02-27 | 3,720,103 | +1.2% | 123,219 | 30.19 |
| 2026-02-13 | 3,676,250 | +0.3% | 372,828 | 9.86 |
| 2026-01-30 | 3,664,089 | +32.2% | 280,426 | 13.07 |
| 2026-01-15 | 2,771,966 | +7.5% | 152,945 | 18.12 |
| 2025-12-31 | 2,577,650 | +6.8% | 210,604 | 12.24 |
| 2025-12-15 | 2,412,586 | -0.4% | 157,211 | 15.35 |
| 2025-11-28 | 2,422,239 | +11.9% | 156,750 | 15.45 |
| 2025-11-14 | 2,165,458 | +24.6% | 230,025 | 9.41 |
| 2025-10-31 | 1,737,864 | -2.0% | 122,376 | 14.20 |
| 2025-10-15 | 1,773,014 | -9.8% | 118,997 | 14.90 |
| 2025-09-30 | 1,964,536 | -15.4% | 173,803 | 11.30 |
| 2025-09-15 | 2,322,070 | -6.3% | 222,901 | 10.42 |
| 2025-08-29 | 2,479,494 | +5.8% | 110,317 | 22.48 |
| 2025-08-15 | 2,343,997 | -0.9% | 72,412 | 32.37 |
| 2025-07-31 | 2,364,276 | +4.9% | 134,923 | 17.52 |
| 2025-07-15 | 2,254,163 | +0.5% | 140,808 | 16.01 |
| 2025-06-30 | 2,242,677 | +8.6% | 245,543 | 9.13 |
| 2025-06-13 | 2,064,629 | +3.5% | 92,213 | 22.39 |
| 2025-05-30 | 1,994,383 | +12.2% | 149,539 | 13.34 |
| 2025-05-15 | 1,776,829 | -12.8% | 261,225 | 6.80 |
| 2025-04-30 | 2,036,809 | +17.1% | 165,457 | 12.31 |
| 2025-04-15 | 1,738,716 | +14.5% | 169,053 | 10.29 |
| 2025-03-31 | 1,518,983 | -4.8% | 177,398 | 8.56 |
| 2025-03-14 | 1,595,028 | +1.7% | 167,062 | 9.55 |
| 2025-02-28 | 1,568,707 | +11.0% | 213,982 | 7.33 |
| 2025-02-14 | 1,413,449 | +138.0% | 465,332 | 3.04 |
| 2025-01-31 | 593,782 | +210.9% | 206,257 | 2.88 |
| 2025-01-15 | 191,007 | -0.4% | 285,572 | 1.00 |
| 2024-12-31 | 191,818 | -5.4% | 95,881 | 2.00 |
| 2024-12-13 | 202,762 | +1.6% | 92,744 | 2.19 |
| 2024-11-29 | 199,593 | -9.9% | 71,392 | 2.80 |
| 2024-11-15 | 221,427 | -14.3% | 93,422 | 2.37 |
| 2024-10-31 | 258,487 | +11.9% | 126,742 | 2.04 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of LFVN volume is 59.4%, up 24.0 points over the last five sessions. Over the last 30 readings it ranged from 21.4% (29 September 2026) to 83.2% (6 October 2026). The latest reading is 17.2 points above the 30-session average of 42.3%, on 8K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 5K | 8K | 59.4% | 99 |
| 2026-10-30 | 8K | 12K | 69.1% | 20 |
| 2026-10-29 | 2K | 9K | 24.1% | 0 |
| 2026-10-28 | 2K | 6K | 28.4% | 0 |
| 2026-10-27 | 3K | 7K | 42.2% | 0 |
| 2026-10-26 | 5K | 14K | 35.4% | 0 |
| 2026-10-23 | 9K | 14K | 61.0% | 0 |
| 2026-10-22 | 5K | 10K | 51.9% | 23 |
| 2026-10-21 | 7K | 9K | 72.5% | 223 |
| 2026-10-20 | 3K | 9K | 35.0% | 0 |
| 2026-10-19 | 6K | 18K | 34.0% | 0 |
| 2026-10-16 | 3K | 7K | 42.6% | 0 |
| 2026-10-15 | 4K | 17K | 26.0% | 384 |
| 2026-10-14 | 7K | 28K | 26.3% | 50 |
| 2026-10-13 | 5K | 11K | 44.0% | 0 |
| 2026-10-12 | 3K | 7K | 52.8% | 0 |
| 2026-10-09 | 3K | 12K | 28.2% | 300 |
| 2026-10-08 | 6K | 19K | 29.8% | 5 |
| 2026-10-07 | 3K | 8K | 36.3% | 0 |
| 2026-10-06 | 12K | 14K | 83.2% | 12 |
| 2026-10-05 | 5K | 10K | 47.0% | 0 |
| 2026-10-02 | 7K | 29K | 23.1% | 100 |
| 2026-10-01 | 5K | 17K | 31.5% | 0 |
| 2026-09-30 | 6K | 9K | 64.2% | 0 |
| 2026-09-29 | 2K | 8K | 21.4% | 0 |
| 2026-09-28 | 7K | 12K | 60.8% | 600 |
| 2026-09-25 | 788 | 2K | 38.9% | 0 |
| 2026-09-24 | 4K | 9K | 39.0% | 0 |
| 2026-09-23 | 13K | 49K | 26.4% | 0 |
| 2026-09-22 | 4K | 12K | 33.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in LFVN is 987 shares, up 951 shares over the last settlement date. Over the last 30 readings it ranged from 36 shares (13 October 2026) to 9,095 shares (26 August 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 987 | $5.95 | $6K |
| 2026-10-13 | 36 | $5.98 | $215 |
| 2026-10-09 | 96 | $5.99 | $575 |
| 2026-10-06 | 1,487 | $6.03 | $9K |
| 2026-09-29 | 449 | $6.19 | $3K |
| 2026-09-21 | 3,764 | $6.35 | $24K |
| 2026-09-17 | 2,659 | $6.18 | $16K |
| 2026-09-11 | 1,245 | $6.37 | $8K |
| 2026-09-10 | 818 | $6.51 | $5K |
| 2026-09-01 | 4,833 | $6.33 | $31K |
| 2026-08-28 | 1,844 | $6.45 | $12K |
| 2026-08-27 | 2,582 | $6.61 | $17K |
| 2026-08-26 | 9,095 | $6.84 | $62K |
| 2026-08-25 | 8,587 | $6.84 | $59K |
| 2026-08-24 | 253 | $6.69 | $2K |
| 2026-08-21 | 558 | $6.65 | $4K |
| 2026-08-20 | 57 | $6.50 | $371 |
| 2026-08-17 | 3,271 | $6.57 | $21K |
| 2026-08-13 | 3,714 | $6.51 | $24K |
| 2026-08-12 | 4,106 | $6.66 | $27K |
| 2026-08-11 | 7,357 | $6.68 | $49K |
| 2026-08-10 | 190 | $6.76 | $1K |
| 2026-08-05 | 3,958 | $6.83 | $27K |
| 2026-08-04 | 419 | $6.58 | $3K |
| 2026-08-03 | 1,479 | $6.43 | $10K |
| 2026-07-29 | 7,602 | $6.43 | $49K |
| 2026-07-24 | 2,883 | $6.27 | $18K |
| 2026-07-23 | 1,947 | $6.35 | $12K |
| 2026-07-22 | 608 | $6.40 | $4K |
| 2026-07-16 | 8,613 | $6.20 | $53K |
Insider trades
SEC Form 4, newest first. JSONOver the last 90 days LFVN insiders reported 1 open-market buy ($6K) against 2 sells ($56K), so the dollar flow leans toward selling. Latest filing: Moorehead Terrence (President and CEO) on 2026-10-07.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Moorehead Terrence | President and CEO | Grant | 193K | $0.00 | $0 | 502K |
| 2026-10-07 | Cunningham Kristen | Chief Sales Officer | Grant | 33K | $0.00 | $0 | 152K |
| 2026-10-07 | Aure Carl | Chief Financial Officer | Grant | 36K | $0.00 | $0 | 192K |
| 2026-10-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 637 | $6.24 | $4K | 120K |
| 2026-10-01 | Aure Carl | Chief Financial Officer | Tax withholding | 460 | $6.24 | $3K | 156K |
| 2026-09-15 | Lewis Darwin | Director | Buy | 976 | $6.22 | $6K | 138K |
| 2026-09-14 | Cunningham Kristen | Chief Sales Officer | Sell | 9K | $6.18 | $55K | 120K |
| 2026-09-11 | Cunningham Kristen | Chief Sales Officer | Sell | 100 | $6.41 | $641 | 129K |
| 2026-09-10 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 2K | $6.37 | $14K | 129K |
| 2026-09-10 | Aure Carl | Chief Financial Officer | Tax withholding | 2K | $6.37 | $12K | 156K |
| 2026-08-06 | Moorehead Terrence | President and CEO | Grant | 309K | $0.00 | $0 | 309K |
| 2026-07-01 | Neufeld Alissa | General Counsel | Tax withholding | 1K | $6.25 | $8K | 113K |
| 2026-07-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 2K | $6.25 | $11K | 131K |
| 2026-07-01 | Aure Carl | Chief Financial Officer | Tax withholding | 1K | $6.25 | $9K | 156K |
| 2026-06-15 | Lewis Darwin | Director | Buy | 705 | $8.60 | $6K | 137K |
| 2026-06-03 | BEINDORFF MICHAEL A | Director | Sell | 10K | $8.55 | $85K | 42K |
| 2026-04-01 | Neufeld Alissa | General Counsel | Tax withholding | 1K | $4.20 | $6K | 114K |
| 2026-04-01 | Fife Steven R | President and CEO | Tax withholding | 8K | $4.20 | $34K | 735K |
| 2026-04-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 2K | $4.20 | $8K | 133K |
| 2026-04-01 | Aure Carl | Chief Financial Officer | Tax withholding | 2K | $4.20 | $6K | 157K |
| 2026-03-16 | Lewis Darwin | Director | Buy | 1K | $5.23 | $6K | 137K |
| 2026-03-02 | Dayton Judd | Director | Buy | 11K | $4.53 | $48K | 80K |
| 2026-02-27 | Dayton Judd | Director | Buy | 18K | $4.63 | $84K | 70K |
| 2026-02-26 | Dayton Judd | Director | Buy | 5K | $4.58 | $21K | 52K |
| 2026-02-09 | Lewis Darwin | Director | Buy | 4K | $5.22 | $21K | 136K |
| 2026-01-01 | Neufeld Alissa | General Counsel | Tax withholding | 1K | $6.16 | $9K | 116K |
| 2026-01-01 | Fife Steven R | President and CEO | Tax withholding | 9K | $6.16 | $56K | 744K |
| 2026-01-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 2K | $6.16 | $12K | 135K |
| 2026-01-01 | Aure Carl | Chief Financial Officer | Tax withholding | 2K | $6.16 | $9K | 158K |
| 2025-12-23 | Thompson Todd | Chief Information Officer | Tax withholding | 601 | $6.23 | $4K | 51K |
| 2025-12-15 | Lewis Darwin | Director | Buy | 805 | $6.54 | $5K | 132K |
| 2025-11-25 | BEINDORFF MICHAEL A | Director | Gift | 8K | $0.00 | $0 | 52K |
| 2025-11-25 | BEINDORFF MICHAEL A | Director | Gift | 8K | $0.00 | $0 | 28K |
| 2025-11-19 | BEINDORFF MICHAEL A | Director | Sell | 13K | $6.42 | $81K | 44K |
| 2025-11-07 | BEINDORFF MICHAEL A | Director | Sell | 35K | $6.92 | $242K | 56K |
| 2025-11-07 | BEINDORFF MICHAEL A | Director | Sell | 1K | $7.33 | $7K | 35K |
| 2025-11-06 | Lewis Darwin | Director | Grant | 14K | $7.76 | $105K | 131K |
| 2025-11-06 | Latham Cynthia | Director | Grant | 14K | $7.76 | $105K | 65K |
| 2025-11-06 | Greer Raymond B | Director | Grant | 14K | $7.76 | $105K | 113K |
| 2025-11-06 | Dayton Judd | Director | Grant | 14K | $7.76 | $105K | 47K |
| 2025-11-06 | BEINDORFF MICHAEL A | Director | Grant | 14K | $7.76 | $105K | 36K |
| 2025-11-06 | Anbalagan Rajendran | Director | Grant | 14K | $7.76 | $105K | 24K |
| 2025-10-01 | Neufeld Alissa | General Counsel | Tax withholding | 1K | $9.56 | $12K | 117K |
| 2025-10-01 | Fife Steven R | President and CEO | Tax withholding | 8K | $9.56 | $78K | 753K |
| 2025-10-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 2K | $9.56 | $16K | 137K |
| 2025-10-01 | Boyster Julie | Chief Marketing Officer | Tax withholding | 2K | $9.56 | $18K | 150K |
| 2025-10-01 | Aure Carl | Chief Financial Officer | Tax withholding | 1K | $9.56 | $13K | 160K |
| 2025-09-16 | Lewis Darwin | Director | Buy | 450 | $10.85 | $5K | 117K |
| 2025-09-09 | BEINDORFF MICHAEL A | Director | Sell | 200 | $11.35 | $2K | 126 |
| 2025-09-09 | BEINDORFF MICHAEL A | Director | Sell | 4K | $11.44 | $47K | 23K |
| 2025-08-31 | Neufeld Alissa | General Counsel | Tax withholding | 16K | $13.10 | $206K | 118K |
| 2025-08-31 | Neufeld Alissa | General Counsel | Exercise or conversion | 19K | $0.00 | $0 | 134K |
| 2025-08-31 | Neufeld Alissa | General Counsel | Exercise or conversion | 14K | $0.00 | $0 | 115K |
| 2025-08-31 | Fife Steven R | President and CEO | Tax withholding | 98K | $13.10 | $1.3M | 761K |
| 2025-08-31 | Fife Steven R | President and CEO | Exercise or conversion | 109K | $0.00 | $0 | 859K |
| 2025-08-31 | Fife Steven R | President and CEO | Exercise or conversion | 91K | $0.00 | $0 | 750K |
| 2025-08-31 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 22K | $13.10 | $286K | 139K |
| 2025-08-31 | Cunningham Kristen | Chief Sales Officer | Exercise or conversion | 26K | $0.00 | $0 | 161K |
| 2025-08-31 | Cunningham Kristen | Chief Sales Officer | Exercise or conversion | 18K | $0.00 | $0 | 134K |
| 2025-08-31 | Boyster Julie | Chief Marketing Officer | Tax withholding | 23K | $13.10 | $305K | 152K |
| 2025-08-31 | Boyster Julie | Chief Marketing Officer | Exercise or conversion | 28K | $0.00 | $0 | 175K |
| 2025-08-31 | Boyster Julie | Chief Marketing Officer | Exercise or conversion | 19K | $0.00 | $0 | 147K |
| 2025-08-31 | Aure Carl | Chief Financial Officer | Tax withholding | 17K | $13.10 | $218K | 161K |
| 2025-08-31 | Aure Carl | Chief Financial Officer | Exercise or conversion | 19K | $0.00 | $0 | 178K |
| 2025-08-31 | Aure Carl | Chief Financial Officer | Exercise or conversion | 15K | $0.00 | $0 | 159K |
| 2025-08-26 | Neufeld Alissa | General Counsel | Grant | 9K | $0.00 | $0 | 101K |
| 2025-08-26 | Fife Steven R | President and CEO | Grant | 48K | $0.00 | $0 | 660K |
| 2025-08-26 | Cunningham Kristen | Chief Sales Officer | Grant | 12K | $0.00 | $0 | 116K |
| 2025-08-26 | Boyster Julie | Chief Marketing Officer | Grant | 13K | $0.00 | $0 | 128K |
| 2025-08-26 | Aure Carl | Chief Financial Officer | Grant | 10K | $0.00 | $0 | 144K |
| 2025-07-01 | Neufeld Alissa | General Counsel | Tax withholding | 3K | $13.39 | $37K | 92K |
| 2025-07-01 | Neufeld Alissa | General Counsel | Exercise or conversion | 3K | $0.00 | $0 | 94K |
| 2025-07-01 | Fife Steven R | President and CEO | Tax withholding | 21K | $13.39 | $282K | 611K |
| 2025-07-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 3K | $13.39 | $45K | 104K |
| 2025-07-01 | Cunningham Kristen | Chief Sales Officer | Exercise or conversion | 3K | $0.00 | $0 | 107K |
| 2025-07-01 | Boyster Julie | Chief Marketing Officer | Tax withholding | 4K | $13.39 | $53K | 115K |
| 2025-07-01 | Boyster Julie | Chief Marketing Officer | Exercise or conversion | 4K | $0.00 | $0 | 119K |
| 2025-07-01 | Aure Carl | Chief Financial Officer | Sell | 3K | $13.39 | $37K | 133K |
| 2025-07-01 | Aure Carl | Chief Financial Officer | Exercise or conversion | 2K | $0.00 | $0 | 136K |
| 2025-06-13 | Lewis Darwin | Director | Buy | 9 | $12.78 | $115 | 117K |
| 2025-06-13 | Lewis Darwin | Director | Buy | 370 | $12.86 | $5K | 117K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 298 | $12.25 | $4K | 33K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 298 | $12.25 | $4K | 33K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 298 | $12.25 | $4K | 33K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 298 | $12.25 | $4K | 33K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 601 | $12.25 | $7K | 86K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 59 | $12.25 | $723 | 7K |
| 2025-05-09 | Mauro Garry Paul | Director | Buy | 298 | $12.25 | $4K | 33K |
| 2025-04-28 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 4K | $12.14 | $44K | 104K |
| 2025-04-01 | Boyster Julie | Chief Marketing Officer | Exercise or conversion | 4K | $0.00 | $0 | 119K |
| 2025-04-01 | Boyster Julie | Chief Marketing Officer | Tax withholding | 4K | $15.79 | $63K | 116K |
| 2025-04-01 | Aure Carl | Chief Financial Officer | Exercise or conversion | 2K | $0.00 | $0 | 135K |
| 2025-04-01 | Aure Carl | Chief Financial Officer | Tax withholding | 3K | $15.79 | $43K | 132K |
| 2025-04-01 | Cunningham Kristen | Chief Sales Officer | Exercise or conversion | 3K | $0.00 | $0 | 111K |
| 2025-04-01 | Cunningham Kristen | Chief Sales Officer | Tax withholding | 3K | $15.79 | $54K | 108K |
| 2025-04-01 | Neufeld Alissa | General Counsel | Tax withholding | 3K | $15.79 | $44K | 92K |
| 2025-04-01 | Neufeld Alissa | General Counsel | Exercise or conversion | 3K | $0.00 | $0 | 95K |
| 2025-04-01 | Fife Steven R | President and CEO | Tax withholding | 21K | $15.79 | $333K | 632K |
| 2025-02-17 | Boyster Julie | Chief Marketing Officer | Tax withholding | 3K | $18.56 | $54K | 116K |
| 2025-02-10 | BEINDORFF MICHAEL A | Director | Sell | 6K | $19.54 | $114K | 44K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for LFVN worth $453K at the prices reported; 0 in the last 90 days worth $0. Latest: BEINDORFF MICHAEL A filed on 2026-06-03 to sell 10,000 shares ($87K) from 2026-06-03.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-06-03 | BEINDORFF MICHAEL ADirector | 10K | $87K | 0.079% | 2026-06-03 | CHARLES SCHWAB & CO |
| 2025-11-07 | BEINDORFF MICHAEL ADirector | 54K | $365K | 0.426% | 2025-11-07 | Charles Schwab & Co |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of LFVN in their latest filing, all on Schedule 13G (passive). The largest reported stake is The Capital Management Corporation at 18.3% of the class (2,307,489 shares), filed 2026-10-22 for an event on 2026-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-22 | 13G/Ano. 5 | The Capital Management Corporationinvestment adviser | 2.3M | 18.3% | 2026-09-30 |
| 2026-08-13 | 13G/Ano. 6 | Renaissance Technologies LLCinvestment adviser | 669K | 5.3% | 2026-04-01 |
| 2026-08-13 | 13G/Ano. 6 | Renaissance Technologies Holdings Corporationparent holding company | 669K | 5.3% | 2026-04-01 |
| 2026-07-29 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 229K | 1.8% | 2026-06-30 |
13F holders
Tracked managers holding LFVN at their latest 13F. JSON5 of the 30 tracked managers held LFVN at their latest 13F, $6.1M in total at quarter-end prices. Renaissance Technologies is the largest at $4.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 669K | $4.2M | 0.01% | -198K |
| AQR Capital Management | 2026-06-30 | 113K | $706K | 0.00% | -43K |
| Citadel Advisors | 2026-06-30 | 100K | $623K | 0.00% | +23K |
| Millennium Management | 2026-06-30 | 70K | $439K | 0.00% | new |
| Point72 Asset Management | 2026-06-30 | 29K | $180K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q4 FY 2026 (quarter ended 2026-06-30) Lifevantage reported revenue of $42.4M, down 23.1% from the same quarter a year earlier, and net income of $1.3M. In FY 2026 it generated $10.2M of operating cash flow and spent $2.0M on buybacks and $2.3M on dividends.
- Equity
- $33.6M
- Total assets
- $62.1M
- Shares outstanding
- 12,527,348
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q4 FY 2026derived | 2026-06-30 | $42.4M | $1.3M | 3.0% | n/a |
| Q3 FY 2026 | 2026-03-31 | $43.7M | $1.4M | 3.1% | 0.11 |
| Q2 FY 2026 | 2025-12-31 | $48.9M | $276K | 0.6% | 0.02 |
| Q1 FY 2026 | 2025-09-30 | $47.6M | $2.2M | 4.5% | 0.17 |
| Q4 FY 2025derived | 2025-06-30 | $55.1M | $2.0M | 3.6% | n/a |
| Q3 FY 2025 | 2025-03-31 | $58.4M | $3.5M | 5.9% | 0.26 |
| Q2 FY 2025 | 2024-12-31 | $67.8M | $2.5M | 3.8% | 0.19 |
| Q1 FY 2025 | 2024-09-30 | $47.2M | $1.8M | 3.9% | 0.14 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $182.6M | $5.1M | $10.2M | $3.6M | $2.0M | $2.3M |
| FY 2025 | 2025-06-30 | $228.5M | $9.8M | $11.9M | $1.4M | $3.1M | $2.1M |
| FY 2024 | 2024-06-30 | $200.2M | $2.9M | $12.2M | $2.2M | $6.4M | $6.9M |
| FY 2023 | 2023-06-30 | $213.4M | $2.5M | $6.8M | $3.1M | $822K | $1.6M |
| FY 2022 | 2022-06-30 | $206.4M | $3.1M | $8.0M | $1.5M | $8.8M | $378K |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-26 from the cover page.
What this page is
Lifevantage in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Lifevantage (LFVN), SEC CIK 849146, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-03.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-22.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-07.JSON and CSV
- Company record
- EDGAR filing index for CIK 849146Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of LFVN is sold short?
What is LFVN's daily short volume?
Does LFVN have fails to deliver?
Are LFVN insiders buying or selling?
Have LFVN insiders filed to sell?
Who owns 5% or more of LFVN?
What did LFVN report last quarter?
Which tracked 13F managers own LFVN?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.